Buprenorphine Hydrochloride and Naloxone Hydrochloride
- Generic Name
- Buprenorphine Hydrochloride and Naloxone Hydrochloride
- Indication
用于治疗鸦片类药物成瘾的患者。
INDV-6001 Multiple-Dose Pharmacokinetic Study
- Conditions
- Moderate to Severe Opioid Use Disorder
- Interventions
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT06576843
- Locations
- 🇺🇸
Artemis Institute for Clinical Research, San Diego, California, United States
🇺🇸Innovative Clinical Research, Inc., Miami Lakes, Florida, United States
🇺🇸Chicago Clinical Research Institute Inc., Chicago, Illinois, United States
Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP
- Conditions
- Hepatitis CHivOpioid Use DisorderOpioid UseRisk Reduction
- Interventions
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Duke University
- Target Recruit Count
- 17
- Registration Number
- NCT05108935
- Locations
- 🇺🇸
Duke Department of Population Health Sciences, Durham, North Carolina, United States
🇺🇸NC Survivors Union, Greensboro, North Carolina, United States
Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder
- Conditions
- Healthy VolunteerOpioid-use Disorder
- Interventions
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT04976855
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
🇺🇸InSite Clinical Research, DeSoto, Texas, United States
🇺🇸Johns Hopkins University School of Medicine BPRU, Baltimore, Maryland, United States
Providing Suboxone and PrEP Using Telemedicine
- Conditions
- Opioid UseRisk ReductionOpioid-use DisorderHiv
- Interventions
- Drug: PrEP
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- Duke University
- Target Recruit Count
- 17
- Registration Number
- NCT04521920
- Locations
- 🇺🇸
North Carolina Harm Reduction Coalition, Wilmington, North Carolina, United States
🇺🇸Queen City Needle Exchnge, Charlotte, North Carolina, United States
🇺🇸Duke Department of Population Health Sciences, Durham, North Carolina, United States
Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT03744663
Houston Emergency Opioid Engagement System
- Conditions
- Opioid Use Disorder
- Interventions
- Behavioral: Brief counseling in the EDBehavioral: Referral to outpatient treatmentBehavioral: Follow-up coaching
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2024-12-11
- Target Recruit Count
- 1500
- Registration Number
- NCT03396276
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Single Ascending Dose Study of RBP-6000
- First Posted Date
- 2016-12-26
- Last Posted Date
- 2016-12-26
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03002961
- Locations
- 🇺🇸
Vince and Associates Clinical Research, Overland Park,, Kansas, United States
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence
- First Posted Date
- 2016-03-02
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- Butler Hospital
- Target Recruit Count
- 21
- Registration Number
- NCT02696096
- Locations
- 🇺🇸
Butler Hospital, Providence, Rhode Island, United States
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
- Conditions
- Opioid Use Disorder
- Interventions
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT02559973
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Overland Park, Kansas, United States
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
- Conditions
- Opioid Use DisorderOpioid-related Disorders
- Interventions
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 775
- Registration Number
- NCT02510014
- Locations
- 🇺🇸
Haleyville Clinical Research, Haleyville, Alabama, United States
🇺🇸Boyett Health Services, Hamilton, Alabama, United States
🇺🇸Collaborative Neuroscience Network, Garden Grove, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.